Work

Teclistamab for BCMA-positive relapsed/refractory B acute lymphoblastic leukemia

Year: 2026

Type: article

Abstract: Not available.

Source: Haematologica

DOI: 10.3324/haematol.2026.301458

Authors: Chezi Ganzel, Ariella Tvito, Mohammad Abu Eid, Yishai Ofran, Sarah Matarasso Greenfeld

Institutions: Hebrew University of Jerusalem, Shaare Zedek Medical Center, Bikur Cholim Hospital

Language: English

Topic: Acute Lymphoblastic Leukemia research

Subfield: Public Health, Environmental and Occupational Health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $2,157

OpenAlex ID: W7212149978

FWCI:

Cites:

Cited by:

Related to: